Premium
Cyclic Adenosine Monophosphate Decreases the Secretion, but not the Cell‐Associated Levels, of Interleukin‐1β in Lipopolysaccharide‐Activated Human Monocytes
Author(s) -
VIHERLUOTO J.,
PALKAMA T.,
SILVENNOINEN O.,
HURME M.
Publication year - 1991
Publication title -
scandinavian journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.934
H-Index - 88
eISSN - 1365-3083
pISSN - 0300-9475
DOI - 10.1111/j.1365-3083.1991.tb01527.x
Subject(s) - forskolin , intracellular , secretion , lipopolysaccharide , monocyte , extracellular , cytokine , endocrinology , adenosine , medicine , cyclic adenosine monophosphate , interleukin , chemistry , biology , microbiology and biotechnology , stimulation , receptor
Interleukin‐1β (IL‐1β) is a cytokine produced mainly by activated monocytes though the mechanism by which it is released is still unknown. Elevation of intracellular cyclic adenosine monophosphate (cAMP) is considered an important down‐regulative signal in the production of IL‐1β in lipopolysaccharide (LPS)‐induced monocytes. In this study we show that in LPS‐activated human monocytes, elevated cAMP concentrations (induced by either prostaglandin E2, forskolin or dibutyrylcyclic AMP) affected specifically secretion of IL‐1β; the amount of secreted IL‐β was clearly reduced whereas the cell‐associated level remained unchanged. TNF‐α, a normal secretory protein, was used as a control. Cyclic AMP also inhibited TNF production by monocytes, but the decrease was of the same magnitude in the extracellular and intracellular compartments. Thus, the down‐regulative effect of cAMP on the production of these monokines is clearly different.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom